Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events

BACKGROUND: The primary goal of phase 2 and 3 clinical trials is to evaluate the safety and effectiveness of therapeutic interventions, and efficient and reproducible ascertainment of important clinical events, either as clinical outcome events (COEs) or adverse events (AEs), is critical. Clinical o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Trials
Glavni autori: Fanaroff, Alexander C., Haque, Ghazala, Thomas, Betsy, Stone, Allegra E., Perkins, Lynn M., Wilson, Matthew, Jones, W. Schuyler, Melloni, Chiara, Mahaffey, Kenneth W., Alexander, Karen P., Lopes, Renato D.
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2020
Teme:
Commentary
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7147037/
https://ncbi.nlm.nih.gov/pubmed/32272961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04254-w
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items